Success of GeneProof STI Panel in QCMD Testing

The aim of the Sexually Transmitted Infections EQA programme was to assess the ability to detect and determine a range of sexually transmitted infections known to cause disease using their routine molecular diagnostic platform and procedures.

What are the main outtakes?
 

• Thanks to its complete STI Solution, GeneProof is one of the few manufacturers able to identify all pathogens included in the panel.
   
• GeneProof was the only manufacturer to detect all samples correctly – confirming its ability of error-free differential diagnostics.
   

Among the PCR kits, that excelled in this QCMD challenge, were GeneProof MH/UU/UP Multiplex and GeneProof CT/NG/MG Multiplex PCR Kits. Thanks to one workflow philosophy, you can use them together in a single run and get many results.

For further details read the QCMD 2020 Sexually Transmited Infections Individual Report